Human Phenotype Ontology 
Grandparent Node:
expand
Cognitive impairment (HP:0100543)help
Parent Node:
expand
Mental deterioration (HP:0001268)help
..Starting node
..expand
Progressive neurologic deterioration (HP:0002344)help
Term ID: 2344
Name: Progressive neurologic deterioration
Synonym: Neurologic deterioration; Neurologic deterioration, progressive; Progressive mental deterioration; Progressive neurodegeneration; Worsening neurological symptoms
Definition:
Comments:
Reference: HP:0002344
Genes and Diseases:
 
       Child Nodes:
........expandProgressive language deterioration (HP:0007064) help
........expandProgressive psychomotor deterioration (HP:0007272) help
........expandRapid neurologic deterioration (HP:0007307) help

 Sister Nodes: 
..expandDementia (HP:0000726) help
..expandMotor deterioration (HP:0002333) help
..expandPsychomotor deterioration (HP:0002361) help
..expandSocial and occupational deterioration (HP:0007086) help
InputHPO IDHPO termDistanceGeneGene id entrezHGNC IDDiseaseIdDiseaseNameFrequencyOnsetHGMD variantsClinVar variants
 
HPO disease - gene - phenotype typical associations:
 
HPO disease - gene - phenotype less frequent non-typical associations:
HP:0002344HP:0002344Progressive neurologic deterioration0ALDH18A1 CL E G H58329722ORPHA:447757Autosomal dominant spastic paraplegia type 9BHP:0040282 - Frequent89
HP:0002344HP:0002344Progressive neurologic deterioration0ARSA CL E G H410713ORPHA:309271Metachromatic leukodystrophy, adult form253
HP:0002344HP:0002344Progressive neurologic deterioration0ARSA CL E G H410713ORPHA:309263Metachromatic leukodystrophy, juvenile form253
HP:0002344HP:0002344Progressive neurologic deterioration0ATP1A2 CL E G H477800ORPHA:2131Alternating hemiplegia of childhoodHP:0040283 - Occasional239
HP:0002344HP:0002344Progressive neurologic deterioration0ATP1A3 CL E G H478801ORPHA:2131Alternating hemiplegia of childhoodHP:0040283 - Occasional150
HP:0002344HP:0002344Progressive neurologic deterioration0BSCL2 CL E G H2658015832ORPHA:363400Severe neurodegenerative syndrome with lipodystrophy105
HP:0002344HP:0002344Progressive neurologic deterioration0CACNA1A CL E G H7731388ORPHA:2131Alternating hemiplegia of childhoodHP:0040283 - Occasional449
HP:0002344HP:0002344Progressive neurologic deterioration0CERS1 CL E G H1071514253OMIM:616230Epilepsy, progressive myoclonic, 81
HP:0002344HP:0002344Progressive neurologic deterioration0CNTNAP2 CL E G H2604713830ORPHA:163681CNTNAP2-related developmental and epileptic encephalopathy518
HP:0002344HP:0002344Progressive neurologic deterioration0CNTNAP2 CL E G H2604713830OMIM:610042Pitt-Hopkins-Like syndrome 1518
HP:0002344HP:0002344Progressive neurologic deterioration0CTNS CL E G H14972518OMIM:219800Cystinosis, nephropathic.178
HP:0002344HP:0002344Progressive neurologic deterioration0CYC1 CL E G H15372579OMIM:615453Mitochondrial complex III deficiency, nuclear type 612
HP:0002344HP:0002344Progressive neurologic deterioration0CYP27A1 CL E G H15932605ORPHA:909Cerebrotendinous xanthomatosis114
HP:0002344HP:0002344Progressive neurologic deterioration0EPM2A CL E G H79573413OMIM:254780Myoclonic epilepsy of lafora.83
HP:0002344HP:0002344Progressive neurologic deterioration0ERCC6 CL E G H20743438OMIM:214150Cerebrooculofacioskeletal syndrome 1199
HP:0002344HP:0002344Progressive neurologic deterioration0ERCC6 CL E G H20743438ORPHA:90324Cockayne syndrome type 3HP:0040283 - Occasional199
HP:0002344HP:0002344Progressive neurologic deterioration0ERCC8 CL E G H11613439ORPHA:90324Cockayne syndrome type 3HP:0040283 - Occasional55
HP:0002344HP:0002344Progressive neurologic deterioration0GALC CL E G H25814115ORPHA:206448Adult Krabbe diseaseHP:0040283 - Occasional160
HP:0002344HP:0002344Progressive neurologic deterioration0GALC CL E G H25814115ORPHA:206436Infantile Krabbe diseaseHP:0040281 - Very frequent160
HP:0002344HP:0002344Progressive neurologic deterioration0GBA1 CL E G H26294177OMIM:608013Gaucher disease, perinatal lethal.
HP:0002344HP:0002344Progressive neurologic deterioration0GBA1 CL E G H26294177OMIM:230900Gaucher disease, type II.
HP:0002344HP:0002344Progressive neurologic deterioration0GBA1 CL E G H26294177OMIM:231000Gaucher disease, type III.
HP:0002344HP:0002344Progressive neurologic deterioration0GCH1 CL E G H26434193OMIM:233910Hyperphenylalaninemia, BH4-deficient, B.86
HP:0002344HP:0002344Progressive neurologic deterioration0GLB1 CL E G H27204298OMIM:230600Gm1-gangliosidosis, type II120
HP:0002344HP:0002344Progressive neurologic deterioration0GRN CL E G H28964601OMIM:607485Frontotemporal lobar degeneration with TDP43 inclusions126
HP:0002344HP:0002344Progressive neurologic deterioration0HEPACAM CL E G H22029626361OMIM:613925Megalencephalic leukoencephalopathy with subcortical cysts 2A.82
HP:0002344HP:0002344Progressive neurologic deterioration0HEXB CL E G H30744879OMIM:268800Sandhoff disease80
HP:0002344HP:0002344Progressive neurologic deterioration0HIBCH CL E G H262754908ORPHA:88639Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiencyHP:0040281 - Very frequent32
HP:0002344HP:0002344Progressive neurologic deterioration0HNF4A CL E G H31725024ORPHA:263455Hyperinsulinism due to HNF4A deficiencyHP:0040282 - Frequent138
HP:0002344HP:0002344Progressive neurologic deterioration0HSD17B10 CL E G H30284800OMIM:300438HSD10 mitochondrial disease.19
HP:0002344HP:0002344Progressive neurologic deterioration0IDUA CL E G H34255391OMIM:607014Hurler syndrome.115
HP:0002344HP:0002344Progressive neurologic deterioration0ITM2B CL E G H94456174OMIM:176500Cerebral amyloid angiopathy, itm2b-related, 1.3
HP:0002344HP:0002344Progressive neurologic deterioration0KARS1 CL E G H37356215OMIM:619196DEAFNESS, CONGENITAL, AND ADULT-ONSET PROGRESSIVE LEUKOENCEPHALOPATHY; DEAPLE
HP:0002344HP:0002344Progressive neurologic deterioration0KCTD7 CL E G H15488121957ORPHA:263516Progressive myoclonic epilepsy type 3106
HP:0002344HP:0002344Progressive neurologic deterioration0LMNB1 CL E G H40016637OMIM:169500Leukodystrophy, adult-onset, autosomal dominant.44
HP:0002344HP:0002344Progressive neurologic deterioration0LRPPRC CL E G H1012815714ORPHA:70472Congenital lactic acidosis, Saguenay-Lac-Saint-Jean typeHP:0040282 - Frequent191
HP:0002344HP:0002344Progressive neurologic deterioration0MCOLN1 CL E G H5719213356OMIM:252650Mucolipidosis IV.78
HP:0002344HP:0002344Progressive neurologic deterioration0MICOS13 CL E G H12598833702OMIM:618329COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37
HP:0002344HP:0002344Progressive neurologic deterioration0NAGLU CL E G H46697632OMIM:252920Mucopolysaccharidosis type IIIB.72
HP:0002344HP:0002344Progressive neurologic deterioration0NDUFA6 CL E G H47007690OMIM:618253Mitochondrial complex I deficiency, nuclear type 33.1
HP:0002344HP:0002344Progressive neurologic deterioration0NHLRC1 CL E G H37888421576OMIM:254780Myoclonic epilepsy of lafora.77
HP:0002344HP:0002344Progressive neurologic deterioration0PDGFRB CL E G H51598804OMIM:616592Kosaki overgrowth syndrome.28
HP:0002344HP:0002344Progressive neurologic deterioration0PMPCA CL E G H2320318667ORPHA:1170Autosomal recessive cerebelloparenchymal disorder type 37
HP:0002344HP:0002344Progressive neurologic deterioration0PSAP CL E G H56609498ORPHA:206436Infantile Krabbe diseaseHP:0040281 - Very frequent81
HP:0002344HP:0002344Progressive neurologic deterioration0PSAP CL E G H56609498OMIM:611722KRABBE DISEASE, ATYPICAL, DUE TO SAPOSIN A DEFICIENCY81
HP:0002344HP:0002344Progressive neurologic deterioration0PSAP CL E G H56609498ORPHA:309271Metachromatic leukodystrophy, adult form81
HP:0002344HP:0002344Progressive neurologic deterioration0PSAP CL E G H56609498ORPHA:309263Metachromatic leukodystrophy, juvenile form81
HP:0002344HP:0002344Progressive neurologic deterioration0PTS CL E G H58059689OMIM:261640Hyperphenylalaninemia, BH4-deficient, A.19
HP:0002344HP:0002344Progressive neurologic deterioration0QDPR CL E G H58609752OMIM:261630Hyperphenylalaninemia, bh4-deficient, C.43
HP:0002344HP:0002344Progressive neurologic deterioration0RAB27A CL E G H58739766OMIM:607624Griscelli syndrome, type 2HP:0040283 - Occasional67
HP:0002344HP:0002344Progressive neurologic deterioration0RNU4ATAC CL E G H10015168334016OMIM:210710Microcephalic osteodysplastic primordial dwarfism, type I15
HP:0002344HP:0002344Progressive neurologic deterioration0RRM2B CL E G H5048417296OMIM:612075Mitochondrial DNA depletion syndrome 8A (encephalomyopathic type with renal tubulopathy).125
HP:0002344HP:0002344Progressive neurologic deterioration0SDHA CL E G H638910680ORPHA:3208Isolated succinate-CoQ reductase deficiency304
HP:0002344HP:0002344Progressive neurologic deterioration0SDHAF1 CL E G H64409633867ORPHA:3208Isolated succinate-CoQ reductase deficiency16
HP:0002344HP:0002344Progressive neurologic deterioration0SDHB CL E G H639010681ORPHA:3208Isolated succinate-CoQ reductase deficiency237
HP:0002344HP:0002344Progressive neurologic deterioration0SDHD CL E G H639210683ORPHA:3208Isolated succinate-CoQ reductase deficiency129
HP:0002344HP:0002344Progressive neurologic deterioration0SLC13A3 CL E G H6484914430OMIM:618384Leukoencephalopathy, acute reversible, with increased urinary alpha-ketoglutarate2
HP:0002344HP:0002344Progressive neurologic deterioration0SLC1A3 CL E G H650710941ORPHA:2131Alternating hemiplegia of childhoodHP:0040283 - Occasional63
HP:0002344HP:0002344Progressive neurologic deterioration0SLC39A14 CL E G H2351620858OMIM:617013Hypermanganesemia with dystonia 25
HP:0002344HP:0002344Progressive neurologic deterioration0SUMF1 CL E G H28536220376ORPHA:585Multiple sulfatase deficiency80
HP:0002344HP:0002344Progressive neurologic deterioration0SUMF1 CL E G H28536220376OMIM:272200Multiple sulfatase deficiency80
HP:0002344HP:0002344Progressive neurologic deterioration0SYNJ1 CL E G H886711503OMIM:617389Epileptic encephalopathy, early infantile, 53.9
HP:0002344HP:0002344Progressive neurologic deterioration0TIMMDC1 CL E G H513001321OMIM:618251MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN311
HP:0002344HP:0002344Progressive neurologic deterioration0TINF2 CL E G H2627711824OMIM:268130Revesz syndrome.60
HP:0002344HP:0002344Progressive neurologic deterioration0TREX1 CL E G H1127712269ORPHA:247691Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestationsHP:0040283 - Occasional56
HP:0002344HP:0002344Progressive neurologic deterioration0VCP CL E G H741512666ORPHA:329478Adult-onset distal myopathy due to VCP mutationHP:0040282 - Frequent63
HP:0002344HP:0007272Progressive psychomotor deterioration1ARSA CL E G H410713ORPHA:309271Metachromatic leukodystrophy, adult formHP:0040283 - Occasional253
HP:0002344HP:0007272Progressive psychomotor deterioration1ARSA CL E G H410713ORPHA:309263Metachromatic leukodystrophy, juvenile formHP:0040283 - Occasional253
HP:0002344HP:0007272Progressive psychomotor deterioration1BSCL2 CL E G H2658015832ORPHA:363400Severe neurodegenerative syndrome with lipodystrophyHP:0040281 - Very frequent105
HP:0002344HP:0007064Progressive language deterioration1CNTNAP2 CL E G H2604713830ORPHA:163681CNTNAP2-related developmental and epileptic encephalopathy518
HP:0002344HP:0007064Progressive language deterioration1CNTNAP2 CL E G H2604713830OMIM:610042Pitt-Hopkins-Like syndrome 1.518
HP:0002344HP:0007272Progressive psychomotor deterioration1CYP27A1 CL E G H15932605ORPHA:909Cerebrotendinous xanthomatosisHP:0040282 - Frequent114
HP:0002344HP:0007272Progressive psychomotor deterioration1GLB1 CL E G H27204298OMIM:230600Gm1-gangliosidosis, type II.120
HP:0002344HP:0007064Progressive language deterioration1GRN CL E G H28964601OMIM:607485Frontotemporal lobar degeneration with TDP43 inclusions.126
HP:0002344HP:0007272Progressive psychomotor deterioration1HEXB CL E G H30744879OMIM:268800Sandhoff disease.80
HP:0002344HP:0007272Progressive psychomotor deterioration1KCTD7 CL E G H15488121957ORPHA:263516Progressive myoclonic epilepsy type 3HP:0040282 - Frequent106
HP:0002344HP:0007272Progressive psychomotor deterioration1PMPCA CL E G H2320318667ORPHA:1170Autosomal recessive cerebelloparenchymal disorder type 3HP:0040282 - Frequent7
HP:0002344HP:0007272Progressive psychomotor deterioration1PSAP CL E G H56609498ORPHA:309271Metachromatic leukodystrophy, adult formHP:0040283 - Occasional81
HP:0002344HP:0007272Progressive psychomotor deterioration1PSAP CL E G H56609498ORPHA:309263Metachromatic leukodystrophy, juvenile formHP:0040283 - Occasional81
HP:0002344HP:0007272Progressive psychomotor deterioration1SDHA CL E G H638910680ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent304
HP:0002344HP:0007272Progressive psychomotor deterioration1SDHAF1 CL E G H64409633867ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent16
HP:0002344HP:0007272Progressive psychomotor deterioration1SDHB CL E G H639010681ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent237
HP:0002344HP:0007272Progressive psychomotor deterioration1SDHD CL E G H639210683ORPHA:3208Isolated succinate-CoQ reductase deficiencyHP:0040282 - Frequent129
HP:0002344HP:0007307Rapid neurologic deterioration1SUMF1 CL E G H28536220376OMIM:272200Multiple sulfatase deficiency.80
HP:0002344HP:0007307Rapid neurologic deterioration1SUMF1 CL E G H28536220376ORPHA:585Multiple sulfatase deficiencyHP:0040281 - Very frequent80


Genes (56) :ALDH18A1 ARSA ATP1A2 ATP1A3 BSCL2 CACNA1A CERS1 CNTNAP2 CTNS CYC1 CYP27A1 EPM2A ERCC6 ERCC8 GALC GBA1 GCH1 GLB1 GRN HEPACAM HEXB HIBCH HNF4A HSD17B10 IDUA ITM2B KARS1 KCTD7 LMNB1 LRPPRC MCOLN1 MICOS13 NAGLU NDUFA6 NHLRC1 PDGFRB PMPCA PSAP PTS QDPR RAB27A RNU4ATAC RRM2B SDHA SDHAF1 SDHB SDHD SLC13A3 SLC1A3 SLC39A14 SUMF1 SYNJ1 TIMMDC1 TINF2 TREX1 VCP

Diseases (55) :ORPHA:447757 ORPHA:309271 ORPHA:309263 ORPHA:2131 ORPHA:363400 OMIM:616230 ORPHA:163681 OMIM:610042 OMIM:219800 OMIM:615453 ORPHA:909 OMIM:254780 OMIM:214150 ORPHA:90324 ORPHA:206448 ORPHA:206436 OMIM:608013 OMIM:230900 OMIM:231000 OMIM:233910 OMIM:230600 OMIM:607485 OMIM:613925 OMIM:268800 ORPHA:88639 ORPHA:263455 OMIM:300438 OMIM:607014 OMIM:176500 OMIM:619196 ORPHA:263516 OMIM:169500 ORPHA:70472 OMIM:252650 OMIM:618329 OMIM:252920 OMIM:618253 OMIM:616592 ORPHA:1170 OMIM:611722 OMIM:261640 OMIM:261630 OMIM:607624 OMIM:210710 OMIM:612075 ORPHA:3208 OMIM:618384 OMIM:617013 ORPHA:585 OMIM:272200 OMIM:617389 OMIM:618251 OMIM:268130 ORPHA:247691 ORPHA:329478
 

Human Phenotype Ontology(HPO) is developed by the Human Phenotype Ontology Consortium. The version used here is December 15 2022 release.